HDM1005
A Pharmacokinetic Study of HDM1005 Injection at Different Injection Sites
Huadong Medicine · Phase 1 · Active, not recruiting · Enrollment 135
Participants reaching threshold, %
Source: Cited trial source. The denominator is the source figure, when it states one.
No selected arm reports a responder percent.
Show as table
| Arm | ≥5% | ≥10% | ≥15% | ≥20% |
|---|---|---|---|---|
| Cohort 1 (Abdomen) | n/r | n/r | n/r | n/r |
| Cohort 2 (Upper arm) | n/r | n/r | n/r | n/r |
| Cohort 3 (Thigh) | n/r | n/r | n/r | n/r |
Not shown
- Cohort 1 (Abdomen): endpoint not reported
- Cohort 2 (Upper arm): endpoint not reported
- Cohort 3 (Thigh): endpoint not reported